Frovatriptan succinate
Frovatriptan succinate: 1 brand, 5 generics; first approved Nov 08, 2001; generic available.
Generic available: 5 ANDA applications approved.
Brand (NDA) products
- FROVARLDENDO OPERATIONSNDA 0210062001
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Discontinued —
Generic (ANDA) products (5)
- FROVATRIPTAN SUCCINATELEADINGANDA 2169982025
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Rx AB - FROVATRIPTAN SUCCINATERSRENATAANDA 2138912022
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Rx AB - FROVATRIPTAN SUCCINATEAMNEAL PHARMS COANDA 2112922018
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Rx AB - FROVATRIPTAN SUCCINATEGLENMARK PHARMS LTDANDA 2047302016
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Rx AB - FROVATRIPTAN SUCCINATEPHARMOBEDIENTANDA 2029312014
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2.5MG BASE TABLET ORAL Discontinued —
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 2001–2025 across 6 FDA applications.
Frovatriptan succinate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Go beyond the database.
Try Assyro Intelligence for your regulatory research. Ready to discuss your team’s workflow? Book a demo.